SETTLEMENT AGREEMENTSettlement Agreement • March 30th, 2023 • Humanigen, Inc • Pharmaceutical preparations • Delaware
This SETTLEMENT AGREEMENT (the “Agreement”) is executed on December 16, 2022 (the “Signing Date”) to be effective as of September 30, 2022 (the “Effective Date”) and entered into by and between Catalent Pharma Solutions, LLC, a Delaware limited liability company with offices at 14 Schoolhouse Road, Somerset, New Jersey, 08873 (“Catalent”), and Humanigen Inc. (f/k/a KaloBios Pharmaceuticals, Inc.), a Delaware corporation with offices at 830 Morris Turnpike, 4th Floor, Short Hills, NJ 07078-2625 (for itself and on behalf of its affiliates, “Humanigen”). Humanigen and Catalent are collectively referred to herein as the “Parties”.
